Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 State of the Art Frontline Management of the HR-MDS
The partial clinical hold for studies investigating magrolimab in combination with azacitidine in MDS and ...
read more ↘
read more ↘
Login to view comments.
Click here to Login